The tribulations of community-based trials
CMAJ January 6, 2004; 170 (1)
Doctors and the medical profession are facing some troubling issues as clinical trials sponsored by the pharmaceutical industry migrate from academic settings into the community. The issue of industry-sponsored clinical trials is "a bit of a hornet's nest," says Dr. David Naylor, dean of medicine at the University of Toronto. He says that "staying on top of perverse incentives and hidden conflicts of interest" is like trying to hit "a constantly moving target."
Weapons of mass salvation: Canada's role in improving the health of the global poor
CMAJ January 6, 2004; 170 (1)
A new Canadian commitment to global health, for all its challenges, represents an unprecedented opportunity to improve global health and reduce poverty over the next 2 decades.
Open access publishing takes off
BMJ 2004;328:1-3 (3 January).For supporters of open access publishing, these are heady times. Over the past year the campaign to make the full text of original research articles freely available via the world wide web has made rapid progress.
